Interpace Biosciences Inc (IDXG)

Currency in USD
1.2050
+0.0750(+6.64%)
Closed·
IDXG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.15001.2050
52 wk Range
0.44331.6800
Key Statistics
Prev. Close
1.13
Open
1.15
Day's Range
1.15-1.205
52 wk Range
0.4433-1.68
Volume
2.22K
Average Volume (3m)
11.12K
1-Year Change
41.76%
Book Value / Share
-0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDXG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Interpace Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Interpace Biosciences Inc Company Profile

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier; and RespriDx, a genomic test that enables physicians to differentiate metastatic or recurrent lung cancer. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

Compare IDXG to Peers and Sector

Metrics to compare
IDXG
Peers
Sector
Relationship
P/E Ratio
1.4x8.7x−0.6x
PEG Ratio
−0.010.050.00
Price/Book
−16.8x1.1x2.6x
Price / LTM Sales
0.1x1.1x3.4x
Upside (Analyst Target)
-28.5%40.2%
Fair Value Upside
Unlock−3.4%5.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
8.76M / --
EPS Revisions
Last 90 days

IDXG Income Statement

People Also Watch

29.87
TCMD
-1.22%
0.1779
VASO
+0.62%
116.57
NICE
-0.43%
7.090
BCRX
-4.19%

FAQ

What Is the Interpace Biosciences (IDXG) Stock Price Today?

The Interpace Biosciences stock price today is 1.2050

What Stock Exchange Does Interpace Biosciences Trade On?

Interpace Biosciences is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Interpace Biosciences?

The stock symbol for Interpace Biosciences is "IDXG."

What Is the Interpace Biosciences Market Cap?

As of today, Interpace Biosciences market cap is 5.34M.

What Is Interpace Biosciences's Earnings Per Share (TTM)?

The Interpace Biosciences EPS (TTM) is 0.11.

When Is the Next Interpace Biosciences Earnings Date?

Interpace Biosciences will release its next earnings report on Mar 05, 2026.

From a Technical Analysis Perspective, Is IDXG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Interpace Biosciences Stock Split?

Interpace Biosciences has split 2 times.

How Many Employees Does Interpace Biosciences Have?

Interpace Biosciences has 111 employees.

What is the current trading status of Interpace Biosciences (IDXG)?

As of Jan 13, 2026, Interpace Biosciences (IDXG) is trading at a price of 1.2050, with a previous close of 1.1300. The stock has fluctuated within a day range of 1.1500 to 1.2050, while its 52-week range spans from 0.4433 to 1.6800.

What Is the IDXG After Hours Price?

IDXG's last after hours stock price is 1.2500, the stock has decreased by 0.0100, or 0.8100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.